Weight Loss from Calorie Restriction Decreases BMD in Older Adults
December 13, 2006 on 11:48 am | In Uncategorized | Comments Off Sanofi-Aventis announces that concerning the New Drug Application for Rimonabant in the United States, the Food and Drug Administration has considered its October 26, 2006 resubmission to be a complete, class 2 response to the FDA February 17, 2006 action letter.New Study Find Links between Acidity and Obesity
December 13, 2006 on 11:48 am | In Uncategorized | Comments Off The latest study by a group of U.S. researchers suggests that patients with gastro esophageal reflux disease (GRD), commonly known as acid reflux (or acidity), are more likely to be suffering from obesity.Rimonabant Update in the United States
December 8, 2006 on 11:48 am | In Uncategorized | Comments Off Sanofi-Aventis announces that concerning the New Drug Application for Rimonabant in the United States, the Food and Drug Administration has considered its October 26, 2006 resubmission to be a complete, class 2 response to the FDA February 17, 2006 action letter.Scale-obsessed teen girls more likely to diet poorly
December 7, 2006 on 11:48 am | In Uncategorized | Comments Off Teen girls who frequently weighed themselves were more likely than others to resort to unhealthy dieting measures, and some ended up gaining close to twice as much weight, a study of Minnesota students found.Pfizer Says Diet Drug Acomplia May Soon Have Competitors
December 1, 2006 on 11:48 am | In Uncategorized | Comments Off Pfizer Inc., the world's largest drug maker, said on Nov. 30th that two of its experimental obesity drugs appeared to be as effective for weight loss as the Sanofi-Aventis diet drug Acomplia.
Powered by WordPress with Pool theme design by Borja Fernandez.